Paydirt
SP
Insider

Sanj K Patel

CHAIRMAN & CEO · Kiniksa Pharmaceuticals International

Sanj K Patel (CHAIRMAN & CEO) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Kiniksa Pharmaceuticals International, plc (KNSA). The largest single filing was $37.4M of KNSA (402,394 sh across 14 lots, as filed), executed Oct 30. Data as of Nov 8 2026.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
5
0 buys · 5 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$81.1M
shares × price, as filed
Last traded
Nov 4
Filed Nov 6

Median ADV $60.8M across their filed names

Open performance→
Volume by month
$51.7M$25.9M$0Dec 2024Jun 2025Dec 2025Jun 2026May 2025 · sells $2.5MOct 2025 · sells $10.0MApr 2026 · sells $26.8MMay 2026 · sells $2.6MNov 2026 · sells $51.7M
Buys $0 Sells $93.7M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 5 filings

Sector per market data · by filing · past 12 months

Most traded names
KNSA Kiniksa Pharmaceuticals International, plc KNSA · 0 buys · 9 sells 9 filings
Recent filings
KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $14.3M
151,300 sh across 5 lots
Exec Nov 4
Filed Nov 6 · 4:52 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $37.4M
402,394 sh across 14 lots
Exec Oct 30
Filed Nov 3 · 7:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $2.6M
48,565 sh × $54.02
Exec May 1
Filed May 1 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $26.4M
508,339 sh across 6 lots
Exec Apr 28
Filed Apr 30 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $364K
7,278 sh × $50.01
Exec Apr 6
Filed Apr 8 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $10.0M
257,969 sh across 4 lots
Exec Oct 20 2025
Filed Oct 22 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $2.3M
86,270 sh across 3 lots
Exec May 23 2025
Filed May 28 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $163K
6,029 sh × $27.05
Exec May 9 2025
Filed May 9 2025 · 5:30 PM ET More filings →